Deadline Set for Generic Drugmakers to Withdraw Pending ANDAs, Avoid Backlog Fee

Drug Industry Daily
A A
Generic drugmakers have until Sept. 28 to either withdraw pending ANDAs or face a backlog fee, the FDA says.

To View This Article:

Login

Subscribe To Drug Industry Daily